Patents by Inventor Alan Moses

Alan Moses has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Adaptive system for optimizing a drug dosage regimen over time
    Patent number: 10293109
    Abstract: A system for optimizing a patient's basal insulin dosage regimen over time, adapted to determine from blood glucose values whether and by how much to vary a patient's present recommended amount of the insulin-containing drug in order to maintain the patient's future blood glucose level measurements within a predefined range, and wherein a given blood glucose value is disregarded if no patient-actuated operation being indicative of the administration of a dose of an insulin containing drug has been detected in a pre-defined amount of time prior to the determination of the given blood glucose value.
    Type: Grant
    Filed: September 11, 2012
    Date of Patent: May 21, 2019
    Assignee: Novo Nordisk A/S
    Inventors: Henrik Bengtsson, Anders Dejgaard, Alan Moses
  • Adaptive System for Optimizing a Drug Dosage Regimen Over Time
    Publication number: 20140371682
    Abstract: A system for optimizing a patient's basal insulin dosage regimen over time, adapted to determine from blood glucose values whether and by how much to vary a patient's present recommended amount of the insulin-containing drug in order to maintain the patient's future blood glucose level measurements within a predefined range, and wherein a given blood glucose value is disregarded if no patient-actuated operation being indicative of the administration of a dose of an insulin containing drug has been detected in a pre-defined amount of time prior to the determination of the given blood glucose value.
    Type: Application
    Filed: September 11, 2012
    Publication date: December 18, 2014
    Applicant: NOVO NORDISK A/S
    Inventors: Henrik Bengtsson, Anders Dejgaard, Alan Moses
  • Integrated Sample Acquisition and Analyte Measurement Device
    Publication number: 20080027302
    Abstract: A region of skin, other than the fingertips, is stimulated. After stimulation, an opening is created in the skin (e.g., by lancing the skin) to cause a flow of body fluid from the region. At least a portion of this body fluid is transported to a testing device where the concentration of analyte (e.g., glucose) in the body fluid is then determined. It is found that the stimulation of the skin provides results that are generally closer to the results of measurements from the fingertips, the traditional site for obtaining body fluid for analyte testing.
    Type: Application
    Filed: July 30, 2007
    Publication date: January 31, 2008
    Applicant: TheraSense, Inc.
    Inventors: John Buse, Alan Moses
  • Small volume in vitro analyte sensor with diffusible or non-leachable redox mediator
    Publication number: 20060025662
    Abstract: A region of skin, other than the fingertips, is stimulated. After stimulation, an opening is created in the skin (e.g., by lancing the skin) to cause a flow of body fluid from the region. At least a portion of this body fluid is transported to a testing device where the concentration of analyte (e.g., glucose) in the body fluid is then determined. It is found that the stimulation of the skin provides results that are generally closer to the results of measurements from the fingertips, the traditional site for obtaining body fluid for analyte testing.
    Type: Application
    Filed: September 29, 2005
    Publication date: February 2, 2006
    Applicant: TheraSense, Inc.
    Inventors: John Buse, Alan Moses